Document is current
Any future updates will be listed below
-
Authors
Cheray, Mathilde https://orcid.org/0000-0002-7551-6357
Posada-Pérez, Mercedes
Fragkopoulou, Adamantia https://orcid.org/0000-0001-7715-652X
Rodrigues, Carlos F. D. https://orcid.org/0000-0003-1685-9883
Murgoci, Adriana-Natalia https://orcid.org/0000-0002-4492-6804
Osman, Ahmed M. https://orcid.org/0000-0002-5255-2136
Vázquez-Cabrera, Guillermo https://orcid.org/0000-0003-1708-6712
Škandík, Martin https://orcid.org/0000-0003-2060-9553
Hong, Christine C.
Engskog-Vlachos, Pinelopi
Kanatani, Shigeaki
Li, Yue https://orcid.org/0000-0003-0584-1119
Spulber, Stefan https://orcid.org/0000-0001-8122-6738
Friess, Lara
Sylaidi, Theodora
St-Pierre, Marie-Kim https://orcid.org/0000-0001-5307-1580
Carlson, Lena-Maria
Damdimopoulos, Anastasios
Uhlén, Per https://orcid.org/0000-0003-1446-1062
Kamme, Fredrik
Blomgren, Klas https://orcid.org/0000-0002-0476-7271
Joseph, Bertrand https://orcid.org/0000-0001-5655-9979
- License Information
-
More Information
Article History
Received: 25 June 2025
Revised: 5 February 2026
Accepted: 5 March 2026
First Online: 18 March 2026
Competing interests
: CH and FK are employees of and stockholders in Ionis Pharmaceuticals, Inc. The other authors declare no competing financial interests.
: Experiments were performed in accordance with the Guidelines of the European Union Council, following Swedish regulations for the use of laboratory animals and approved by the Regional Animal Research Ethical Board, Stockholm, Sweden (Ethical permits N248/13, 17283/2018, and 13676/2020).
